MARKET

ILMN

ILMN

Illumina
NASDAQ

Real-time Quotes | Nasdaq Last Sale

369.13
-1.12
-0.30%
After Hours: 368.50 -0.63 -0.17% 17:07 07/13 EDT
OPEN
370.51
PREV CLOSE
370.25
HIGH
382.32
LOW
366.53
VOLUME
949.13K
TURNOVER
--
52 WEEK HIGH
384.21
52 WEEK LOW
196.78
MARKET CAP
54.26B
P/E (TTM)
58.22
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ILMN stock price target is 343.86 with a high estimate of 420.00 and a low estimate of 220.00.

EPS

ILMN News

More
3 Top Healthcare Stocks to Buy Right Now
Motley Fool · 1d ago
Are These Medical Stocks Cruising Toward Big Gains? Here's A Bullish Sign
Medical stocks could be making a comeback this year. The best-performing among them include medical technology companies with high Composite Ratings, a key metric measuring growth.
Investor's Business Daily · 4d ago
Here's Why Adaptive Biotechnologies Soared 61.7% in the First Half of 2020
MotleyFool.com · 4d ago
Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
Business Wire · 5d ago
Illumina Launches TruSight Softaware Suite To Accelerate The Identification Of Genetic Diseases
Benzinga · 5d ago
GILD vs. ILMN: Which Stock Should Value Investors Buy Now?
Zacks · 06/29 16:40
Instagram co-founder who built a coronavirus tracker says it's showing concerning spread levels
"People like to say we're not in a second wave. I don't know what a second wave [is] if that's not a second wave," Instagram co-founder Kevin Systrom told CNBC on Monday.
CNBC.com · 06/29 15:54
Here's Why You Should Hold on to Illumina Stock for Now
Zacks · 06/29 14:44

Industry

Advanced Medical Equipment & Technology
-0.77%
Healthcare Equipment & Supplies
-0.73%

Hot Stocks

Symbol
Price
%Change

About ILMN

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
More

Webull offers kinds of Illumina, Inc. stock information, including NASDAQ:ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ILMN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ILMN stock methods without spending real money on the virtual paper trading platform.